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Psammomys obesus (the Israeli sand rat) has been
well studied as an animal model of Type 2 diabetes.
However, obesity phenotypes in these animals have
not been fully characterized. We analyzed pheno-
typic data including body weight, percentage body
fat, blood glucose and plasma insulin concentration
for over 600 animals from the Psammomys obesus
colony at Deakin University to investigate the
relationships between body fat, body weight and
Type 2 diabetes using regression analysis and
general linear modelling. The body weight distribu-
tion in Psammomys obesus approximates a normal
distribution and closely resembles that observed in
human populations. Animals above the 75th per-
centile for body weight had increased body fat
content and a greater risk of developing diabetes.
Increased visceral fat content was also associated
with elevated blood glucose and plasma insulin
concentrations in these animals. A familial effect
was also demonstrated in Psammomys obesus, and
accounted for 51% of the variation in body weight,
and 23-26% of the variation in blood glucose and
plasma insulin concentrations in these animals.
Psammomys obesus represents an excellent animal
model of obesity and Type 2 diabetes that exhibits a
phenotypic pattern closely resembling that observed
in human population studies. The obesity described
in these animals was familial in nature and was
significantly associated with Type 2 diabetes.
Keywords: Psammomys obesus; Obesity; Type 2 diabetes; Body
fat content; Familial
INTRODUCTION
Obesity may be defined as a pathological in-
crease in body fat content, and is a result of
a sustained imbalance between energy intake
and energy expenditure. It is an extremely
common metabolic disorder, affecting approxi-
mately 17% of adult Australians [1] and 23% of
adult Americans E21 and is epidemic in some
developing countries.
[3] Obesity is an extremely
serious public health problem as it increases
the risk of co-morbidities such as cardiovascular
diseases, Type 2 diabetes, hypertension, muscu-
[4,5] lo-skeletal disorders and certain cancers.
The commonest form of Type 2 diabetes, which
may be defined as a pathological increase in
blood glucose concentration, characteristically
develops in obese, middle-aged individuals and,
if not adequately controlled, can be extremely
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debilitating with further complications includ-
ing blindness, renal failure and peripheral vas-
cular insufficiency. Like obesity, Type 2 diabetes
is highly prevalent in both affluent and de-
veloping societies. In the latter situation, it is
now seen in younger age groups than in Europid
communities and even in adolescence. [6] The
reports of a spectacularly high prevalence of
NIDDM of over 40% in adult Pima Indians of
Arizona[7] and Micronesian Nauruans, Is] have
been followed by other reports including pre-
valences in the Pacific Islands of Kiribati and
Western Samoa of 11% and 16%, respectively,
and a prevalence of 37% in the Melanesians
of Papua New Guinea. [9] At the other end of
the scale, very low prevalences of 1 to 2% have
been found in parts of Africa and China. In
Europid subjects, while there are only a few
studies, they indicate rates around 5% in adult
Australians [10] and Americans. [11]
Research into obesity and Type 2 diabetes
has been much enhanced by the identification of
animal models of these diseases. An excellent
example of the insights into both normal and
pathological processes gained from these mod-
els is that of leptin.
[12] However, the most
utilized animal models, including ob/ob and
db/db mice and fa/fa rats, are single-gene models
and may not closely represent the processes
involved in the pathogenesis of human obesity
and diabetes. This is because these complex
diseases are generally thought to be polygenic
or oligogenic in humans, with only rare and
extreme cases due to single-gene mutations.
For these reasons the development and char-
acterization of polygenic animal models of
obesity and diabetes, which are likely to more
closely reflect the pathological processes in hu-
man disease, are of considerable value to this
field of research. Primates are thought to pro-
vide a very good model of human obesity and
diabetes. However the drawback with these
animals is the difficulty associated with hand-
ling and housing the animals, and the long
lifespan, which complicates longitudinal studies.
Psammomys obesus (the Israeli sand rat) is a
unique rodent model of obesity, insulin resis-
tance and Type 2 diabetes. Its natural habitat is
the desert regions of the Middle East, where it
subsists on a diet of saltbush and remains lean
and normoglycemic.
[13] However, when housed
in laboratory conditions and fed ad libitum
chow, a diet on which many other rodent species
remain healthy, a range of metabolic responses
have been observed. [14,15] By 16 weeks of age
approximately one third of the animals have
normal glucose tolerance, one third are hyperin-
sulinemic and normoglycemic, and one third
develop diabetes. [15] The stages of diabetes devel-
opment have been characterized and defined in
Psammomys obesus, and studies are ongoing to
investigate the physiological processes involved.
Psammomys obesus have hepatic insulin resistance
even before the development of hyperglycemia
and hyperinsulinemia,
[16] and have been shown
to have a defective insulin receptor-signaling
pathway.
[17, 18] Hyperproinsulinemia, reduced
pancreatic insulin storage capacity and beta-cell
apoptosis have also been demonstrated in these
animals. [19,20] Other phenotypes noted include
dyslipidemia and hyperphagia.
[15,21] The rela-
tionship of blood glucose and plasma insulin
concentrations forms a continuous curve in Psam-
momys obesus identical to "Starling’s curve of
the pancreas" in human populations.
[22’231
This heterogeneous response indicates that
Psammomys obesus probably represents a poly-
genic animal model of human diabetes.
Psammomys obesus also exhibit a wide range
of body weight, and may represent a polygenic
animal model of obesity resembling the disease
in human populations. However, the develop-
ment of obesity and characterization of body
weight and body fat distribution have not been
well defined. In this study we analyzed data
from the Psammomys obesus colony at Deakin
University in Geelong, Australia to investigate
the obese phenotype in these animals, and in
particular to define obesity and its relationship
with Type 2 diabetes.OBESITY PHENOTYPES 179
RESEARCH METHODS
AND PROCEDURES
A colony of Psammomys obesus is maintained at
Deakin University, Geelong, Australia. Breeding
pairs are fed ad libitum a diet of lucerne and
chow, and are maintained using the San Poiley
outbreeding method. Data included in this
study were from animals from the 12th to the
16th filial generations. Experimental animals
were weaned at 4 weeks of age and given a
diet of standard laboratory chow, from which
12% of energy was derived from fat, 63% from
carbohydrate and 25% from protein (Barastoc,
Pakenham, Australia). Animals were housed in
a temperature-controlled room (22 + 1C) with
a 12-12 h light-dark cycle (light 06:00-18:00,
dark 18:00- 06:00).
This study included data from 633 animals
from the colony for which phenotypic data was
available at 16 weeks of age, prior to being
included in experiments. Whole blood glucose
was measured using an enzymatic glucose
analyzer (Model 27, Yellow Springs Instruments,
Ohio). Plasma insulin concentrations were de-
termined using a double-antibody solid phase
radioimmunoassay (Phadeseph, Kabi Pharmacia
Diagnostics, Sweden). The antibody in this kit
does not differentiate between insulin and
proinsulin, so some of the insulin measurement
may actually be proinsulin.
Estimates of body fat content in Psammomys
obesus were made by surgically removing and
weighing selected major adipose tissue depots
from animals after sacrifice. These fat depots
included the perirenal, suprascapular (includes
both white and brown adipose tissue), mesen-
teric and intramuscular (from between the
heads of gastrocnemius). The combined weight
of these fat pads was expressed as a percentage
of body weight, and was taken to be an estimate
of percentage body fat in these animals (%fat).
All animals were maintained in accordance
with the Code of Practice of the National Health
and Medical Research Council of Australia, and
all procedures were carried out subject to the
approval of the Deakin University Animal Ex-
perimentation Ethics Committee.
All data are expressed as mean +standard
deviation. Distribution of data was tested using
Kolmogorov-Smirnov test for normality, and
data was normalized by transformation if re-
quired for further analysis. Group means were
tested by one-way ANOVA with a post hoc LSD
test, and relationships between variables were
tested using either linear regression analysis or
general linear model testing. Results were con-
sidered significant at p < 0.05.
RESULTS
Definition and Characterization
of Obesity in Psammomys Obesus
Psammomys obesus from the Deakin University
colony exhibit a wide range of body weight.
Figure 1 shows a frequency histogram for the
body weight variable in a total of 633 animals.
The mean body weight for the colony at 16
weeks of age was 198.7 4- 30.9 g, with a range
from 109-276 g. Male animals were significant-
ly heavier than females (211.7 4- 26.0 vs.
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FIGURE 1 Frequency distribution of body weight at 16-
weeks of age in Psammomys obesus.180 K.R. WALDER et al.
177.2 4- 25.9 g; p < 0.001), and the ranges were
similar (male: 133-276; female: 109-238).
To define obesity in Psammomys obesus, it
would be most appropriate to determine a
cut-off point above which the risk of metabolic
complications is increased. We have collected a
large amount of data pertaining to the devel-
opment of Type 2 diabetes in these animals.
A summary of the distribution into phenotypic
groups at 16 weeks of age is given in Table I.
We have documented a progressive increase
in the body weight of animals from Group A
through to Group C. The body weights of ani-
mals in these groups are shown in Figure 2.
For both sexes, diabetic (Groups C and D)
animals were significantly heavier than Group
B, which in turn were heavier than Group A
(p < 0.001 by ANOVA). These data suggest
that excessive body weight is related to the de-
velopment of insulin resistance and diabetes
in Psammomys obesus. Regression analysis using
general linear modeling confirmed that 20%
of the variation in blood glucose concentration
(after adjustment for gender and plasma insulin
concentration) could be explained by variation
in body weight in these animals.
The risk ratio of developing diabetes was
investigated in the heaviest animals in the
colony. For each sex, at 16 weeks of age, those
animals over the 75th percentile of the body
weight distribution had increased risk of dia-
betes. In males, the 75th percentile was 230g
and animals over this body weight had a 2.3-
fold increased risk, while females over the 75th
percentile (196 g) had a 2.9-fold increased risk
compared with the general Psammomys obesus
population. Therefore, it seems plausible to
define obesity in Psammomys obesus as a body
weight at 16 weeks of age of greater than 230 g
for males, and greater than 196 g for females.
In addition to showing a metabolic risk when
defining obesity, it is obviously important to
demonstrate an increased body fat content in
obese animals. We have also investigated body
TABLE Distribution of 16-week old Psammomys obesus into stages of diabetes development
Group* Male Female Total
A: normoglycemic, normoinsulinemic
B: normoglycemic, hyperinsulinemic
C: hyperglycemic, hyperinsulinemic
D: hyperglycemic, normoinsulinemic
127(38%) 100(48%) 227(42%)
115(35%) 85(40%) 200(37%)
82(25%) 21(10%) 103(19%)
7(2%) 5(2%) 12(2%)
Hyperglycemic blood glucose > 8.0mmol/L; hyperinsulinemic plasma insulin > 150tU/ml.
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FIGURE 2 Body weight (mean 4- s.d.) of Psammomys obesus from each stage of diabetes development. Group A animals were
normoglycemic and normoinsulinemic, Group B were normoglycemic and hyperinsulinemic, Group C were hyperglycemic
and hyperinsulinemic, and Group D were hyperglycemic and hypoinsulinemic. *For both sexes, p < 0.001 by ANOVA.OBESITY PHENOTYPES 181
fat content and distribution in Psammomys obesus
by dissection of the major fat depots after
sacrifice of the animals. The fat depots excised
and weighed include the perirenal, suprasca-
pular, mesenteric and intramuscular (from
between the heads of gastrocnemius). The
weights of each of these individual depots
closely correlated with the body weight of the
animal. Table II lists the partial correlation
coefficients (controlling for sex) and the signi-
ficance level for each of these fat depots with
body weight.
The combined fat pad weight, expressed as
a percentage of total body weight, is normally
distributed in these animals and has been used
as an estimate of percentage body fat in Psam-
momys obesus. This variable was highly correlated
with body weight in these animals (r=0.63,
p K0.001; Fig. 3), although this relationship
is clearly heterogeneous as evidenced by the
variation around the regression lines in Figure
3. In the Deakin University colony, estimated
percentage body fat (%fat) was significantly
increased in Group C (diabetic) animals com-
pared to Group B (hyperinsulinemic) animals,
which in turn had greater %fat than Group A
animals (Fig. 4; p < 0.001 by ANOVA).
If Psammomys obesus were defined as "obese"
as described above (over the 75th percentile),
and animals were defined as "lean" below
the 25th percentile, the %fat for the groups is
shown in Figure 5. As expected, in both males
and females the %fat was significantly greater
in obese compared to lean animals (Fig. 5;
p < 0.001 by ANOVA).
TABLE II Partial correlation coefficients (adjusted for gen-
der) for various fat depots and body weight in Psammomys
obesus
Fat depot Correlation coefficient p-value
Perirenal 0.42 < 0.001
Suprascapular 0.50 < 0.001
Mesenteric 0.39 < 0.001
Intramuscular 0.48 < 0.001
Female
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FIGURE 3 Correlation between %fat and body weight in
female (upper panel) and male (lower panel) Psammomys
obesus. For females, n=235, r=0.63, p < 0.001; for males,
n 380, r 0.63, p < 0.001.
Linear regression analysis was used to in-
vestigate the relationship between %fat and the
individual fat depot weights and diabetes in
Psammomys obesus. The blood glucose concentra-
tion, adjusted for sex, body weight and plasma
insulin, was significantly associated with %fat
(p=0.001), and also independently with the
weight of the perirenal (p < 0.001), mesenteric
(p 0.001) and intramuscular (p 0.006) fat
depots, but not with the suprascapular fat depot
weight. Plasma insulin concentration (adjusted
for sex, body weight and blood glucose) was
also significantly associated with %fat (p<
.0.001), and with perirenal (p 0.003), mesenteric
(p < 0.001) and suprascapular (p < 0.001) fat
depot weights, but not with that of the intra-
muscular fat pad.182 K.R. WALDER et al.
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FIGURE 4 %fat of Psammomys obesus from each stage of diabetes development. Group A animals were normoglycemic and
normoinsulinemic, Group B were normoglycemic and hyperinsulinemic, Group C were hyperglycemic and hyperinsulinemic,
and Group D were hyperglycemic and hypoinsulinemic. *For both sexes, p < 0.001 by ANOVA.
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FIGURE 5 %fat of lean and obese Psammomys obesus. Signi-
ficantly greater than lean male (p < 0.001); **Significantly
greater than lean female (p < 0.001).
A summary of the phenotypic characteristics
of animals classified as lean or obese is given in
Table III. Within both sexes, the obese animals
were significantly heavier, hyperglycemic, hy-
perinsulinemic and fatter than the lean group
(p < 0.001 in all cases, by ANOVA).
Familiality of Obesity Phenotypes
in Psammomys Obesus
To address the question of the contribution of
genetic influences to the development of obesity
in Psammomys obesus, we used regression ana-
lyses with general linear models to assess the
contribution of family membership to various
phenotypic traits. The data included in the ana-
lysis was from a total of 613 animals compris-
ing 166 families. A dummy variable pertaining to
family membership was generated and assigned
to each animal, and this variable was included
in subsequent regression analyses. The number
of siblings per family varied from 1 to 15, with
a mean of 3.7 4-3.0 and a median of 3. All vari-
ables were adjusted for sex prior to analysis.
Table IV lists the estimated genetic influences
on each of the various phenotypic traits ana-
lyzed (calculated from the adjusted regression
coefficients) along with the F- and p-values from
the analysis. The familial effect on body weight
was calculated to be 51%, while the effect on
blood glucose and plasma insulin concentration
were 23% and 26%, respectively. The genetic
contribution to the weights of the individual fat
depots was also calculated, and found to vary
between 22 and 31%.
TABLE III Phenotypic characteristics of lean and obese Psammomys obesus
Male
Lean Obese Lean
Female
Obese
Body weight (g) 178 + 14 244 + 11 144 + 12 209 4- 10
Blood glucose (mmol/L) 4.6 4- 2.1 9.9 4- 5.2 4.3 4- 0.9 7.3 4- 4.5
Plasma insulin (U/ml) 160 4- 335 456 4- 273 86 4- 89 376 4- 273
% fat 2.2 4- 1.1 3.7 4- 1.1 2.6 4- 1.1 4.5 4- 1.4OBESITY PHENOTYPES 183
TABLE IV Familial contribution to phenotypic characteris-
tics of Psammomys obesus
Family effect F-value p-value
Body weight 51% 2.3 < 0.001
%fat 32% 2.3 < 0.001
Blood glucose 23% 1.8 < 0.001
Plasma insulin 26% 2.0 < 0.001
DISCUSSION
Psammomys obesus exhibit a wide range of body
weight and body fat content in a laboratory
setting. The distribution of body weight resem-
bles that in human populations, suggesting that
Psammomys obesus is an excellent rodent model
of human obesity. There is no evidence of a
bimodal distribution, which would be expected
in a single-gene model.
Human obesity is defined based on large-scale
population-based studies in which morbidity
and mortality have been related to body weight
or BMI (body mass index). The definition of
obesity refers to a condition whereby the risk
of adverse health outcomes is increased over
a given BMI, relative body weight or body fat
content. [3’24-26] We have defined obesity in
Psammomys obesus by analyzing the relationships
between body weight, body fat content and
diabetes. We are unable to base this definition on
overall mortality or other obesity co-morbidities,
as these data are not available for this animal.
Using the 75th body weight percentile as a
guide, we propose that obesity be defined as a
body weight at 16 weeks of age of greater than
230 g for male, and greater than 196 g for female
Psammomys obesus. Animals above these arbi-
trary cut-off values for body weight have a
significantly increased risk of developing dia-
betes as well as an elevated body fat content.
The contribution of body fat, both visceral and
subcutaneous, to diabetes phenotypes was also
investigated in Psammomys obesus using linear
regression. Adjusted blood glucose and plasma
insulin concentrations were significantly asso-
ciated with the estimated percentage body fat
(%fat) of the animal. Furthermore, the weights of
the perirenal and mesenteric fat depots were
also significantly and independently associated
with both blood glucose and plasma insulin
concentrations. These are both visceral adipose
tissue stores, and suggest that Psammomys obesus
may also represent a model of visceral obesity.
In humans, visceral adipose tissue carries a
higher risk of developing diseases such as dia-
betes, as well as a higher mortality independent
of obesity per se. [27"281 Our findings in Psam-
momys obesus suggest a relationship between
visceral adipose tissue and insulin resistance,
which needs to be further investigated.
Psammomys obesus exhibit a wide range of
phenotypic responses when removed from their
natural environment and maintained under
laboratory conditions. [13,14] The heterogeneity
of the phenotypes observed under identical
environmental conditions suggests a role for
genetic factors in the disease processes. How-
ever, few studies have attempted to charac-
terize the role of genetic factors in the disease
process in these animals. [29] We used general
linear modeling to analyze the variation within
and between families of Psammomys obesus to
estimate the contribution of genetic factors to
various phenotypic traits (Tab. IV). Our results
suggest that membership in a given family
accounts for 23-26% of the variation in adj-
usted blood glucose and plasma insulin concen-
trations, and approximately half of the variation
in body weight after adjusting for sex. The
familial effect observed strongly supports the
hypothesis that part of the heterogeneous varia-
tion in obesity and diabetes phenotypes in Psam-
momys obesus is due to genetic factors.
The findings of this study add weight to the
suggestion that Psammomys obesus represents
an excellent animal model of human obesity
and Type 2 diabetes that, like humans, is likely
to be polygenic in nature. Detailed phenotypic
characterization of obesity and its relationship
to diabetes in these animals should facilitate
physiological and genetic studies seeking to184 K.R. WALDER et al.
determine the factors involved in both the
etiology and pathology of abnormal energy
balance and carbohydrate metabolism in Psam-
momys obesus. In addition, we also suggest that
these animals provide a good model to investi-
gate the role of visceral adipose tissue in the
development of insulin resistance and diabetes.
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